Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.35% |
| 2 | Technology | 8.73% |
| 3 | Financials | 7.42% |
| 4 | Healthcare | 6.65% |
| 5 | Industrials | 6.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Republic Bancorp
RBCAA
$1.86B
| $1.71M | ﹤0.01% |
23,394
-11,691
| -33% | -$799K |
|
3902
Protara Therapeutics
TARA
$226M
| $1.71M | ﹤0.01% |
564,120
-4,301
| -0.8% | -$14.8K |
|
3903
Utah Medical Products
UTMD
$232M
| $1.71M | ﹤0.01% |
29,980
-2,028
| -6% | -$110K |
|
3904
PUT
Shake Shack
SHAK
$2.82B
| $1.7M | ﹤0.01% |
12,100
-20,700
| -63% | -$2.25M |
|
3905
Atossa Therapeutics
ATOS
$25.7M
| $1.7M | ﹤0.01% |
+136,502
| New | +$1.63M |
|
3906
Allogene Therapeutics
ALLO
$698M
| $1.7M | ﹤0.01% |
1,502,724
+1,245,875
| +485% | +$1.66M |
|
3907
News Corp Class B
NWS
$18.7B
| $1.7M | ﹤0.01% |
+49,449
| New | +$1.57M |
|
|
WSR
3908
DELISTED
Whitestone REIT
WSR
| $1.7M | ﹤0.01% |
135,885
-76,350
| -36% | -$972K |
|
3909
SES AI
SES
$194M
| $1.69M | ﹤0.01% |
1,906,619
+1,285,343
| +207% | +$1.08M |
|
3910
CALL
SolarEdge
SEDG
$1.93B
| $1.69M | ﹤0.01% |
82,900
-4,600
| -5% | -$76.1K |
|
3911
Amdocs
DOX
$6.57B
| $1.69M | ﹤0.01% |
18,480
-48,567
| -72% | -$4.34M |
|
3912
Encore Capital Group
ECPG
$2.1B
| $1.68M | ﹤0.01% |
43,508
+20,533
| +89% | +$745K |
|
3913
Holley
HLLY
$354M
| $1.68M | ﹤0.01% |
837,656
+616,593
| +279% | +$1.31M |
|
3914
CALL
Evolus
EOLS
$587M
| $1.68M | ﹤0.01% |
+181,900
| New | +$1.86M |
|
3915
PepGen
PEPG
$213M
| $1.68M | ﹤0.01% |
1,509,198
+476,180
| +46% | +$673K |
|
3916
CALL
Bunge Global
BG
$22.2B
| $1.67M | ﹤0.01% |
20,800
+1,100
| +6% | +$86.6K |
|
3917
CALL
Clorox
CLX
$12.4B
| $1.67M | ﹤0.01% |
13,900
+8,800
| +173% | +$1.17M |
|
3918
PUT
Teva Pharmaceuticals
TEVA
$42.5B
| $1.67M | ﹤0.01% |
99,500
-60,400
| -38% | -$975K |
|
3919
Greene County Bancorp
GCBC
$594M
| $1.66M | ﹤0.01% |
74,639
+19,039
| +34% | +$422K |
|
3920
Bridgewater Bancshares
BWB
$594M
| $1.66M | ﹤0.01% |
104,164
+76,559
| +277% | +$1.12M |
|
3921
CALL
TripAdvisor
TRIP
$1.16B
| $1.65M | ﹤0.01% |
126,800
-99,600
| -44% | -$1.33M |
|
3922
CALL
BHP
BHP
$242B
| $1.65M | ﹤0.01% |
34,400
-16,100
| -32% | -$774K |
|
3923
Red Violet
RDVT
$1.18B
| $1.65M | ﹤0.01% |
33,607
+258
| +0.8% | +$11.3K |
|
3924
Leslie's
LESL
$4.97M
| $1.65M | ﹤0.01% |
196,693
+53,129
| +37% | +$699K |
|
3925
AirSculpt Technologies
AIRS
$187M
| $1.65M | ﹤0.01% |
+341,834
| New | +$1.16M |
|
Similar funds
Israel Englander's Q2 2025 Portfolio in Review
As of Q2 2025, Israel Englander held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Israel Englander's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Israel Englander added most to Applovin in Q2 2025, an estimated $751M increase.
- Israel Englander's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Israel Englander fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Israel Englander's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Israel Englander opened 738 new positions and closed 712 in Q2 2025.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.